Integra Therapeutics

Integra Therapeutics closes a new investment of €1.5-million with the addition of Columbus Venture Partners to seed round

Integra Therapeutics, a biotechnology company that creates next- generation gene writing tools, has closed an additional €1.5-million investment from venture capital firm Columbus Venture Partners. This investment comes on top of the €4.5 million Integra Therapeutics raised last December from AdBio Partners, Invivo Capital and Takeda Ventures and completes its seed round in line with […]